The second messenger cyclic adenosine monophosphate (cAMP) plays an important role in cell proliferation, differentiation and apoptosis. In the present work, we evaluated the cAMP signaling in acute promyelocytic leukemia (APL) cells in the context of differentiation induced by all-trans retinoic acid (ATRA). There was a marked increase in the intracellular cAMP level within a few minutes after treatment with ATRA in APL cell line NB4 and fresh APL cells, whereas no such phenomenon was observed in NB4-R1 cells that are resistant to ATRAinduced maturation. In addition, the basal level of intracellular cAMP was lower in NB4-R1 than in NB4 cells. Mechanistic study showed that this induction of cAMP was mediated through the activation of adenylate cyclase. Moreover, we found that cAMPdependent protein kinase (PKA) activity was quickly upregulated in parallel in ATRA-treated NB4 cells, and the phosphorylation of RARa by PKA could increase its transactivation effect. Use of H-89, an inhibitor of PKA, could partially suppress the transcriptional expression of ATRA target genes and ATRAinduced differentiation of APL cells. Taken together, we suggested a crosstalk between ATRA-induced cytosolic pathway and nuclear pathway in APL cell differentiation.
Introduction
It is well known that the intracellular level of the second messenger cyclic adenosine monophosphate (cAMP) is controlled by the adenylate cyclase (AC) and the phosphodiesterase (PDE). The elevation of cAMP subsequently activates cAMPdependent protein kinase (PKA) that can phosphorylate various proteins, thus regulating a cascade of transcriptional events implicated in the growth inhibition and differentiation of a broad spectrum of cancer cells, including human leukemia cells, such as HL60 and U937 cells. 1 Acute promyelocytic leukemia (APL) is so far the best model of cancer differentiation therapy. Clinical remission can be achieved in most APL patients using the differentiation inducer, all-trans retinoic acid (ATRA). 2, 3 Since PML-RARa fusion protein, generated from t (15;17) that is exclusively associated with APL, could impair the normal function of PML, RARa as well as retinoid X receptor (RXR) as a dominant mutant, it is considered to be responsible for leukemogenesis of APL. 4 Although numerous evidences showed that the pharmacological concentrations of retinoids (10
À6
-10 À7 mM) could exert their therapeutic effects on APL cells by binding to the ligand-binding domain on the RARa portion of PML-RARa, dissociating the nuclear receptor corepressor (CoR) complex from PML-RARa to relieve the transcriptional repression, 5, 6 triggering the degradation of PML-RARa oncoprotein, 7, 8 and restoring PML nuclear bodies structure from micropunctuated pattern, [9] [10] [11] several reports on the integration of signal crosstalk in the context of APL cell differentiation should hold our attention. [12] [13] [14] [15] [16] For example, the interplay between retinoids and cAMP signaling for maturation was observed in their synergistic effects on APL cell line NB4. Some cAMP agonists can potentiate NB4 cells maturation and render the cells even responsive to physiological levels of retinoids (3-10 nM), whereas disrupting the cAMP signal pathway with cAMP-PKA antagonist will result in a reversible resistance to pharmacological levels of retinoids. 17 In the case of NB4-R1 cells, which derived from NB4, no terminal maturation can occur in the presence of retinoids alone, due to the dissociation of retinoid 'priming' and cAMP activation of secondary effectors, indicating that cAMP-PKA pathway may be an integrated part of the RA signal network. 18 This possibility was further reinforced by the report of the existence of an RARindependent RXR signaling pathway in APL cell maturation, which needs a crosstalk between RXR agonists and PKA signaling. [19] [20] Our recent results showed that cAMP could synergize with a low dose of arsenic trioxide (As 2 O 3 ) to induce terminal maturation of APL cells. 21 Taken together, these data support the notion of an important role for cAMP-PKA pathway to play in the response to hormonal signals for APL cell maturation.
In this study, we investigated the cAMP-PKA signaling in APL cells before and after treatment with ATRA. We found that there was a rapid increase in cAMP levels and PKA activities during ATRA-induced NB4 cell maturation. In contrast, no such change was observed in NB4-R1 cells. We also showed that AC activation could be responsible for this RA-triggered activation of cAMP signaling. Moreover, our results of the integration of cAMP-PKA pathway with nuclear receptor-mediated signaling during ATRA-induced APL cells maturation further support the major role of a cytosolic signal transduction pathway in the therapeutic action of ATRA on APL.
Materials and methods

Reagents
ATRA, SQ22536 (9-(tetrahydro-2-furanyl)-9H-purin-6-amine), P2277 (calmodulin) and 8-CPT (4-chlorophenylthio)-cAMP (Sigma, St Louis, MO, USA) were dissolved in ethanol, DMSO, sterile water and phosphate-buffered saline (PBS) as stock solution at 10 À3 M, 0.1 M, 1000 U/ml and 10 À2 M, respectively, and stored at À201C. Forskolin and IBMX (3- 
Cell culture
NB4 and NB4-R1 cells were cultured in RPMI 1640 supplemented with 10% fetal calf serum (GIBCO-BRL, Gaithersburg, MD, USA), 2 mM L-glutamine, 100 U/ml penicillin and 100 mg/ ml streptomycin. COS-7 cells were cultured in Dulbecco's modified Eagle's medium supplemented with 10% bovine serum, 2 mM L-glutamine. Fresh bone marrow cells were obtained with informed consent from APL patients who were diagnosed by the FAB criteria and showed an initial percentage of circulating blasts over 90%. Leukemia cells were isolated and enriched on Ficoll solution. All cell cultures were incubated at 371C in humidified air with 5% CO 2 . APL cell maturation was evaluated on the basis of cellular morphology, changes in cell surface antigen and nitroblue-tetrazolium (NBT) (Sigma, St Louis, MO, USA) assay. Briefly, Wright's stained cytospin slides were analyzed for cell morphology by means of light microscopy. Analysis of cell surface myeloid-specific antigen CD11b (Coulter, Marseille, France) was performed by flow cytometry (EPICS XL, Coulter, Hialeah, FL, USA). For NBT assay, 1 Â 10 6 cells were centrifuged, suspended in 500 ml PBS and incubated at 371C for 30 min with 1 mg/ml NBT and 30 ng/ml 12-Otetradecanoylphorbol-13-acetate (Sigma, St Louis, MO, USA). The percentage of NBT-positive cells with formazan deposits in the cytoplasm was determined by microscopically counting at least 300 cells per experimental condition.
Quantitative determination of cAMP concentration
The intracellular cAMP content was determined by using the cAMP enzymeimmunoassay (EIA) kit (Amersham pharmacia biotech, Buckinghamshire, UK). Briefly, a total of 2 Â 10 5 cells were washed with PBS and harvested by centrifugation. Cell pellets were then resuspended in lysis reagent provided by the Kit. Lysed cells were immediately used for cAMP immunoassay following the manufacturer's protocol. The assay is based on competition between unlabeled cAMP and a fixed quantity of peroxidase-labeled cAMP, for a limited number of binding sites on a cAMP-specific antibody. Data were represented as fmol per 2 Â 10 5 cells.
PKA activity assay
NB4 and NB4-R1 cells, respectively, untreated and treated with ATRA, were washed twice with cold PBS and homogenized with extraction buffer (5 mM EDTA, 50 mM Tris-Cl, pH 7.5) on ice. Cellular debris was removed by centrifuging at 10 000 g at 41C. The cell lysates were quantified by the Bradford method and then used for in vitro PKA-specific kinase activity determination by PKA Assay System (GIBCOBRL Gaithersburg, MD, USA). Briefly, 10 mg of cell lysate was mixed with PKA inhibitor and/or activator at room temperature for 15 min, then incubated with [g-32 P]ATP/PKA substrate solution containing 50 mM consensus heptapeptide Leu-Arg-Arg-Ala-Ser-Leu-Gly (12.5 mM Tris pH 7.5, 10 mM MgCl 2 , 100 mM ATP, 0.25 mg/ml BSA) at 301C for 5 min. The reaction mixture was then spotted onto p81 phosphocellulose filter disc for scintillation counting. The percentage of activated PKA was calculated according to the manufacturer's instructions.
Cell transient transfection
RARE-TK-luciferase reporter plasmid contains the DR5-RARE retinoic acid response element of the RARb upstream of thymidine kinase promoter. The RARaS369A that harbors mutations in PKA phosphorylation sites and the wild-type RARa constructs were kindly provided by Dr C Rochette-Egly. The expression plasmid encoding the catalytic subunit of PKA was a gift from Dr GS McKnight. COS-7 cells were transfected with 300 ng RARE-TK-luciferase reporter plasmid and related expression plasmids by using 6 ml Lipofectamine reagent (GIBCO-BRL, Gaithersburg, MD, USA) according to the manufacturer's procedure. At 24 h after transfection, cells were, respectively, treated without or with ATRA (1 mM), 8-CPT-cAMP (100 mM) and/ or H-89 (10 mM) for 24 h followed by transcriptional activity assay using the Dual-Luciferase Reporter Assay 1000 System (Promega, Madison, WI, USA) following the manufacturer's instructions. pRL-SV40 vector (30 ng) (Promega, Madison, WI, USA) was cotransfected into COS-7 cells as an internal control.
cDNA array
Membranes with 169 known genes (made by our institute) were used and hybridization using the RNA from three independent sets of NB4-R1 cells, respectively, stimulated by ATRA (1 mM), 8-CPT-cAMP (100 mM) or the combination of 8-CPT-cAMP and ATRA. The signal was analyzed on an FLA-300 screener (FUJI, Japan).
Real-time quantitative RT-PCR and semiquantitative RT-PCR
For quantitative analysis of gene expression, total RNA was extracted with RNAzol reagent (Invitrogen, Carlsbad, CA, USA), then treated with DNase. Complementary DNA was synthesized by using the First cDNA synthesis kit (Roche, Applied Biosystem) according to the manufacturer's instructions. Fluorescence real-time RT-PCR was performed with the doublestranded DNA dye SYBR Green (Roche Applied Biosystem) by using the ABI PRISM 7900 system (Perkin-Elmer). The following gene-specific oligonucleotide primers were used to detect target gene transcripts: long chain Acyl-CoA synthetase, 5 0 -AGT GAA CTG GTG GAA CGA GGC-3 0 (sense) and 5 For semiquantitative RT-PCR, G3PDH was used as an internal control with the following primers: 5 0 -TGA AGG TCG GAG TCA ACG GAT TTG GT-3 0 (sense), and 5 0 -CAT GTG GGC CAT GAG GTC CAC CAC-3 0 (antisense). PCR was performed in 50 ml volumes using the Perkin-Elmer Cycler 9600 (Perkin-Elmer) with the same RNA templates of real-time RT-PCR at the following conditions: 941C for 5 min; 28-32 cycles of 941C for 40 s, 561C for 40 s and 721C for 1-2 min. All RT-PCR reactions were repeated at least three times.
Results
Distinct changes of intracellular cAMP concentration in NB4 cells, fresh APL cells and NB4-R1 cells upon ATRA treatment
Previous studies have indicated that the cAMP signaling pathway played an important role in retinoid-induced differentiation of APL cells. 17, 18 We therefore measured, for the first time, the intracellular cAMP content before and after treatment with ATRA in APL cell lines NB4 and NB4-R1, which are retinoid-induced maturation sensitive and resistant, respectively. Excluding the effect of ETOH in which ATRA was dissolved, we found that 1 mM ATRA could cause a rapid increase of intracellular cAMP concentration, which was surprisingly detected as early as 5 min after the addition of ATRA and maintained until 60 min (Figure 1a) . Importantly, this change was not affected by the transcription inhibitor actinomycin-D (data not shown), suggesting that it is more likely a direct response at cellular membrane or cytosolic levels rather than a secondary event downstream of RAR/RXR or PML-RARa activation. In contrast, little change in cAMP level was observed in NB4-R1 cells. Moreover, we noted that the basal level of intracellular cAMP in NB4-R1 cells was relatively lower than that in NB4 cells (Figure 1a ). This discrepancy between NB4 and NB4-R1 cells might contribute to the different sensitivity of these two cell lines in response to ATRA-induced maturation. To further address the significance of this issue, we determined the intracellular cAMP levels among samples from APL patients. A significant induction of cAMP 'pulse' was also present in fresh APL cells (Figure 1b) , indicating that this response should also be operating in the clinical setting.
Implication of AC in NB4 and NB4-R1 cells during ATRA treatment
Since the intracellular cAMP level is mainly regulated by AC and PDE, the activity of AC or PDE system might be involved in the alteration of cAMP levels triggered by ATRA treatment. By using both inhibitors and activators of the two enzymes, we examined the potential role of AC and PDE in the elevation of intracellular cAMP content as well as in ATRA-induced differentiation. As expected, we found that SQ22536, a specific AC inhibitor, was able to diminish ATRA-triggered intracellular cAMP elevation in NB4 cells (Figure 2e ) and dramatically hamper ATRA-induced NB4 cell differentiation as judged by morphologic observation, CD11b expression detection and NBT test over a period of 96 h (Figure 2a and c) . Of particular note, forskolin, a direct activator of AC, could significantly increase the intracellular cAMP concentration and cooperate with ATRA to induce full maturation of NB4-R1 cells (Figure 2b, d and f) . In contrast, modulation of the activity of PDE system by IBMX (a specific inhibitor) or P2277 (an activator of PDE) exerted little impact on the cAMP levels with regard to ATRA treatment (Figure 2e-f) . The two compounds exhibited no obvious effect on the maturation of both NB4 and NB4-R1 cells (Figure 2a-d) . These observations suggested that the rapid increase of intracellular cAMP during ATRA-induced NB4 cells differentiation might be attributed to the activation of AC. The defaults in the initiation of AC activation, instead of intrinsic AC deficiency, might contribute to the resistance of NB4-R1 cells to ATRAinduced maturation.
PKA activity upregulation in NB4 cells during ATRA-induced differentiation
One of the primary elements in the cAMP signal transduction downstream cascade is the activation of PKA. We thus, respectively, measured PKA activity in NB4 and NB4-R1 cells treated with ATRA for appointed times. We noted that in parallel to the rapid increase of cAMP level, the percentage of activated PKA was increased from 18 to 52% after 10 min treatment of ATRA in NB4 cells and remained relatively elevated at about 30% over 6 h, whereas the activated PKA in NB4-R1 cells was constantly at about 10% during ATRA treatment (Figure 3a) , 
Effects of H-89 on ATRA-induced differentiation in APL cells
The above evidence that the rapid elevation of intracellular cAMP level and almost simultaneous activation of PKA correlated with the APL cell sensitivity to ATRA stimulated us to investigate the possible role of PKA pathway in ATRA differentiation therapy by using H-89, a specific PKA inhibitor. The results of CD11b expression and NBT reduction tests (Figure 3b) , as well as morphological changes (data not shown), showed that H-89 was able to inhibit partly the ATRA-triggered differentiation of NB4 cells in a dose-dependent manner. In keeping with the results, they were also obtained in fresh APL cells using similar experimental conditions (Figure 3c ). Of note, the inhibitory effect of H-89 on NBT test was more obvious; this was probably because the cell NBT reduction activity occurred relatively later than the expression of cell surface integrin CD11b during granulocytic differentiation. These findings further suggested the indispensability of PKA pathway for ATRA-induced APL cell maturation.
Activation of transregulatory effects of RA receptors
After achieving the above-mentioned results, an imperative issue ensued: how could the cAMP-PKA pathway be integrated into ATRA-induced differentiation process in APL cells? It is known that PKA regulates a number of downstream pathways through phosphorylating key proteins. Since the transcriptional activation of RARa-regulated genes is presumably indispensable to the maturation of NB4 cells, [22] [23] [24] [25] we thus hypothesized that the signaling pathways of cAMP-PKA and ATRA might converge at the level of RA receptors. To explore this potential signaling crosstalk, the effect of cAMP-PKA signal pathway on transregulatory activity of RA receptors was examined. Transient transfection of Cos-7 cells with DR5 retinoic acid-responsive element (RARE)-containing reporter gene showed that the effect of ATRA on the reporter gene could be enhanced by cAMP, and this enhancement induced by cAMP could be attenuated by H-89 (Figure 4a, lanes 5 and 7) . Similar results could also be obtained by using Hela cells (data not shown). In order to further define the molecular basis of this crosstalk, we used cotransfection assay of reporter system together with the wild-type RARa or RARaS369A harboring mutation in the PKA phosphorylation site (alanine to serine substitution at position 369 in RARa) (Figure 4b ). In the presence of cAMP, transfection with mutant receptor caused a significantly decreased reporter gene expression as compared to the wild-type receptor (lanes 4 and 10). This observation was subsequently confirmed by the experiment, in which we transfected PKA catalytic subunit into Cos-7 cells (lanes 6 and 12) instead of treatment with cAMP (lane 4 and 10), further exhibiting the importance of PKA phosphorylation of RA receptor for the transcriptional activation of RARa-regulated gene. These results illustrated RA receptor as a unique node of crosstalk between cAMP-PKA and ATRA pathways.
Comparisons of gene expression profile in NB4 and NB4-R1 cells upon treatment with ATRA and/or cAMP
We previously reported the gene expression networks underlying ATRA-induced differentiation of APL cells. 22 Since the transregulatory activity of RARa could be modulated by cAMP-PKA, it would be interesting to perform a systematic survey of gene expression regulation in NB4-R1 cells upon treatment with ATRA, cAMP or their combination. In this study, by using cDNA array as a more global approach, we revealed a number of genes regulated by ATRA and/or cAMP in NB4-R1 cells. The expressions of these genes were further verified by real-time quantitative RT-PCR and semiquantitative RT-PCR, respectively ( Figure 5 ). To be noteworthy, among them some differential gene expressions could also be observed between untreated and treated NB4 cells with ATRA. According to distinct expression patterns, we classified these genes into four parts ( Figure 5 and 
Figure 4
Effect of cAMP-PKA signal pathway on transregulatory activity of RA receptors. (a) Cos-7 cells were transfected with 0.3 mg RARE-TK-luciferase report plasmid. At 24 h after transfection, cells were treated with or without 1 mM ATRA, 10 mM H-89 and/or 100 mM cAMP as indicated. (b) RARE-TK-luciferase report plasmid (0.3 mg) was transfected into Cos-7 cells with indicated plasmids (wild-type RARa, mutant RARaS369A or PKA). At 24 h after transfection, Cos-7 cells were treated with or without 1 mM ATRA, and/or 100 mM cAMP as indicated. Luciferase activity was measured 48 h after the transfection and normalized according to the internal control. The value indicated was a representative experiment among three independent assays. cAMP/PKA pathway in APL cell Q Zhao et al Figure 5 Representative results of gene expression. The NB4-R1 cells were treated with 1 mM ATRA and/or 100 mM cAMP as indicated. The expression of gene was independently measured by real-time RT-PCR (left panel) and semiquantitative RT-PCR (right panel) as described in Materials and methods. All RT-PCR reactions were repeated at least three times. For real-time RT-PCR, all samples were analyzed in triplicate. The level of gene expression was represented as fold relative to that at time zero. Four types of gene expression patterns were observed in treated NB4-R1 cells; genes of part I could be induced only by ATRA, genes of part II could be induced only by cAMP, genes of part III could be regulated by both ATRA and cAMP and genes of part IV could be only modulated by ATRA combined with cAMP. Table 1 cDNA microarray analysis of gene expression patterns in ATRA-and/or cAMP-treated NB4 and NB4-R1 cells
Gene name NB4 cells NB4-R1 cells cAMP/PKA pathway in APL cell Q Zhao et al Table 1 ). Genes in part I were regulated only by ATRA treatment, further confirming that NB4-R1 cells retain transcriptional response to RA, although with maturation failure. Genes in part III responded in a similar manner to ATRA or to cAMP, while those in part IV were regulated only in the presence of both ATRA and cAMP. Both situations could reflect the consequences of interaction among multiple signaling pathways. What is worth mentioning here is the genes in part II. We noted that, although these genes were regulated by ATRA in NB4 cells, their expression modulation occurred only in the presence of cAMP in NB4-R1 cells. This observation reinforced to some extent the notion that some genes regulated by ATRA in NB4 cells may be indeed ascribed to the cAMP-PKA pathway.
Discussion
Over the past decade, the demonstration of PML-RARa as a homodimer to attract high concentration of CoR and as the target for ATRA and As 2 O 3 to undergo either modulation or degradation has made the nuclear receptor signaling a central player in APL pathogenesis and ATRA differentiation therapy. Nevertheless, the question of whether any other signal transduction pathways may also be involved in APL cell maturation remains open. Several arguments support the notion that the crosstalk of multiple signaling pathways is required for hematopoietic differentiation. [12] [13] [14] [15] [16] It has long been recognized that cAMP-PKA pathway plays a key role in the proliferation and differentiation of human myeloid, lymphoid and erythroid progenitor cells. 26 It was reported that cAMP was able to induce morphologic and/or functional differentiation of M1 mouse myeloid leukemia cells and of the human leukemia cell lines HL60, K562 and U937. [27] [28] It could also synergize with retinoids or rexinoids to induce granulocytic differentiation of human APL cells. 19 More recently, we showed that cAMP could dramatically enhance the differentiating effect of As 2 O 3 on both NB4 and NB4-R1 cells, 21 which was further confirmed by in vivo clinical trial results. 29 Although these reports indicated the significant role of cAMP-PKA pathway in the differentiation of granulocytic cells; however, the precise mechanism by which cAMP-PKA integrates into the differentiation process remains obscure.
In this study, we provided experimental evidences that in both NB4 cells and the fresh APL cells, the ATRA-induced differentiation process is associated with a rapid increase in the intracellular cAMP level (Figure 1 ) as well as PKA activity (Figure 3a) , which occurred within an hour of treatment with differentiation inducer. The fact that this response represents a distinct but indispensable early event in the molecular mechanism of ATRA differentiation therapy has been supported by the following observations. Firstly , this response was only present in maturation-sensitive NB4 cells but not in maturationresistant NB4-R1 cells in keeping with the system. Secondly, use of antagonists against either cAMP synthesis or PKA activity could block or attenuate ATRA-induced maturation (Figures 2  and 3) . Thirdly, the transregulatory activity of RA receptor was modulated by cAMP, which was closely related to the PKA phosphorylation of RA receptor ( Figure 4) . As a matter of fact, a similar finding at certain steps of this signal transduction was also reported in the model of teratocarcinoma F9 where the PKA phosphorylation of RARa mediates the RA differentiation response. 30 Finally, cAMP could synergize with ATRA in modulating the gene expression profile necessary for differentiation. In an attempt to investigate the possible mechanism of ATRA-triggered increase of intracellular cAMP level in APL cells, we found that it was the AC but not the PDE enzymatic machinery that was crucial. Hence, a cytosolic to nuclear pathway could be constructed from the activation of the AC to the phosphorylation of RA receptors by PKA, followed by reprogramming the cellular transcriptional machinery. This result is coincident with the finding of elevation of AC activity and cAMP level during human myeloid leukemia cell lines HL60 and RDFD differentiation regardless of the differentiation inducer utilized. 31 The following question can then be raised: how the AC is activated by ATRA considered as a nuclear hormone? Several scenarios could be developed. In the exclusive paradigm of nuclear receptor signaling, one might argue that this response was due to the activation of the RA receptor, followed by gene transcription/translation expression and then a signaling from the nucleus to the cytoplasm. However, the fact that the response was not abrogated by the treatment using transcription inhibitor actinomycin D is strongly against this scenario. A second possibility could be the retinoid binding (retinoylation) of the AC or regulatory subunit of the membrane receptor, which could in their turn activate AC. Actually, it was reported that the retinoylation of some proteins could be found in HL60 cells after being exposed to RA for only 5 min. 32 The remaining hypothesis could then be made for proteins either serving the role as RA-binding proteins such as CRABPs (cellular RAbinding proteins) or as a membrane receptor. In fact, the activation of pleiotropic cytosolic signaling transduction pathways in rapid, nongenomic action of steroid hormones has already been reported in experimental systems with glucocorticoid and the G-protein-protein kinase pathways. 33 In addition, the quick activation of cAMP/PKA pathway discovered in the present work was reminiscent of a finding that STAT1 (signal transducers and activators of transcription) phosphorylation could be observed within 15 min upon ATRA treatment in APL cells. 34 Therefore, the possibility of cytoplasmic membrane receptor/binding protein for ATRA is worth in-depth studies in the future.
Cell maturation is a process with great complexity. It should integrate membrane receptor-mediated signals (such as growth factors and cytokines) and their cytoplasmic nodes of communication (such as cAMP/PKA pathway or ras/raf pathway), which cooperate with the nuclear-protein complexes. It is worth noting that no single signal is likely to work optimally. Responses apparently triggered by a single signal indeed result from crosstalk of diverse signaling pathways, just like the case of ATRA-induced NB4 cell maturation, in which the potential role of cAMP/PKA was masked to some degree. This notion was strongly supported by our data of gene expression profile analysis, several genes that seem to be regulated by ATRA in NB4 cells may be under the control of cAMP/PKA signaling pathway ( Figure 5 and Table 1 ). Our findings support the idea that the coordination of multiple signaling pathways in the cell context is required in the symphony of differentiation and lay the experimental grounds to design the novel combinations of therapeutic drugs to reduce RA doses, thereby minimizing the side effects of RA treatment. Our work opens the possibility that ATRA in combination with cAMP or other differentiation inducers may lead to new clinical applications for leukemia and cancer therapy.
